{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:24:53Z","timestamp":1793395493330,"version":"4.5.0"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STA 1053\/3-1, STA 1053\/3-2, STA 1053\/7-1, STA 1053\/10-1, STA 1053\/11-1, STA 1053\/14-1"],"award-info":[{"award-number":["STA 1053\/3-1, STA 1053\/3-2, STA 1053\/7-1, STA 1053\/10-1, STA 1053\/11-1, STA 1053\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","award":["grant no. 96 876"],"award-info":[{"award-number":["grant no. 96 876"]}],"id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","award":["grant no. 3806"],"award-info":[{"award-number":["grant no. 3806"]}],"id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41587-023-01927-0","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:02:40Z","timestamp":1695297760000},"page":"1526-1542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Precision RNA base editing with engineered and endogenous effectors"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2487-4138","authenticated-orcid":false,"given":"Laura S.","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-3439","authenticated-orcid":false,"given":"Thorsten","family":"Stafforst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"1927_CR1","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1021\/bi300419r","volume":"51","author":"MW Gray","year":"2012","unstructured":"Gray, M. W. Evolutionary origin of RNA editing. Biochemistry 51, 5235\u20135242 (2012).","journal-title":"Biochemistry"},{"key":"1927_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0168-9525(93)90011-6","volume":"9","author":"P Covello","year":"1993","unstructured":"Covello, P. & Gray, M. On the evolution of RNA editing. Trends Genet. 9, 265\u2013268 (1993).","journal-title":"Trends Genet."},{"key":"1927_CR3","doi-asserted-by":"publisher","first-page":"e1007064","DOI":"10.1371\/journal.pgen.1007064","volume":"13","author":"AL Yablonovitch","year":"2017","unstructured":"Yablonovitch, A. L., Deng, P., Jacobson, D. & Li, J. B. The evolution and adaptation of A-to-I RNA editing. PLoS Genet. 13, e1007064 (2017).","journal-title":"PLoS Genet."},{"key":"1927_CR4","doi-asserted-by":"publisher","first-page":"112112","DOI":"10.1016\/j.celrep.2023.112112","volume":"42","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. On the origin and evolution of RNA editing in metazoans. Cell Rep. 42, 112112 (2023).","journal-title":"Cell Rep."},{"key":"1927_CR5","doi-asserted-by":"publisher","first-page":"e1665","DOI":"10.1002\/wrna.1665","volume":"13","author":"B Song","year":"2021","unstructured":"Song, B., Shiromoto, Y., Minakuchi, M. & Nishikura, K. The role of RNA editing enzyme ADAR1 in human disease. Wiley Interdiscip. Rev. RNA 13, e1665 (2021).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"1927_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","volume":"479\u2013480","author":"RS Harris","year":"2015","unstructured":"Harris, R. S. & Dudley, J. P. APOBECs and virus restriction. Virology 479\u2013480, 131\u2013145 (2015).","journal-title":"Virology"},{"key":"1927_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm.2015.4","volume":"17","author":"K Nishikura","year":"2016","unstructured":"Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 17, 83\u201396 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1927_CR8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3390\/genes12071026","volume":"12","author":"C Vesely","year":"2021","unstructured":"Vesely, C. & Jantsch, M. F. An I for an A: dynamic regulation of adenosine deamination-mediated RNA editing. Genes 12, 1026 (2021).","journal-title":"Genes"},{"key":"1927_CR9","doi-asserted-by":"crossref","unstructured":"Pecori, R., Di Giorgio, S., Paulo Lorenzo, J. & Papavasiliou, F. N. Functions and consequences of AID\/APOBEC-mediated DNA and RNA deamination. Nat. Rev. Genet. 23, 505\u2013518 (2022).","DOI":"10.1038\/s41576-022-00459-8"},{"key":"1927_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0092-8674(88)90253-X","volume":"55","author":"BL Bass","year":"1988","unstructured":"Bass, B. L. & Weintraub, H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55, 1089\u20131098 (1988).","journal-title":"Cell"},{"key":"1927_CR11","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1073\/pnas.91.24.11457","volume":"91","author":"U Kim","year":"1994","unstructured":"Kim, U., Wang, Y., Sanford, T., Zeng, Y. & Nishikura, K. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl Acad. Sci. USA 91, 11457\u201311461 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR12","doi-asserted-by":"publisher","first-page":"31795","DOI":"10.1074\/jbc.271.50.31795","volume":"271","author":"T Melcher","year":"1996","unstructured":"Melcher, T. et al. RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J. Biol. Chem. 271, 31795\u201331798 (1996).","journal-title":"J. Biol. Chem."},{"key":"1927_CR13","first-page":"453","volume":"3","author":"A Gerber","year":"1997","unstructured":"Gerber, A., O\u2019Connell, M. A. & Keller, W. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 3, 453\u2013463 (1997).","journal-title":"RNA"},{"key":"1927_CR14","doi-asserted-by":"publisher","first-page":"5376\u20135388","DOI":"10.1128\/MCB.15.10.5376","volume":"15","author":"JB Patterson","year":"1995","unstructured":"Patterson, J. B. & Samuel, C. E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15, 5376\u20135388 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"1927_CR15","doi-asserted-by":"publisher","first-page":"4621\u20134626","DOI":"10.1073\/pnas.96.8.4621","volume":"96","author":"CX George","year":"1999","unstructured":"George, C. X. & Samuel, C. E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl Acad. Sci. USA 96, 4621\u20134626 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0378-1119(00)00368-1","volume":"258","author":"K Kawakubo","year":"2000","unstructured":"Kawakubo, K. & Samuel, C. E. Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 258, 165\u2013172 (2000).","journal-title":"Gene"},{"key":"1927_CR17","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1093\/nar\/gkz815","volume":"47","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. RNA binding candidates for human ADAR3 from substrates of a gain of function mutant expressed in neuronal cells. Nucleic Acids Res. 47, 10801\u201310814 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1017\/S1355838200000170","volume":"6","author":"CX Chen","year":"2000","unstructured":"Chen, C. X. et al. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 6, 755\u2013767 (2000).","journal-title":"RNA"},{"key":"1927_CR19","doi-asserted-by":"publisher","first-page":"E1852","DOI":"10.1073\/pnas.1323698111","volume":"111","author":"P Barraud","year":"2014","unstructured":"Barraud, P., Banerjee, S., Mohamed, W. I., Jantsch, M. F. & Allain, F. H. A bimodular nuclear localization signal assembled via an extended double-stranded RNA-binding domain acts as an RNA-sensing signal for transportin 1. Proc. Natl Acad. Sci. USA 111, E1852\u2013E1861 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1242\/jcs.200055","volume":"130","author":"M Behm","year":"2017","unstructured":"Behm, M., Wahlstedt, H., Widmark, A., Eriksson, M. & Ohman, M. Accumulation of nuclear ADAR2 regulates A-to-I RNA editing during neuronal development. J. Cell Sci. 130, 745\u2013753 (2017).","journal-title":"J. Cell Sci."},{"key":"1927_CR21","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1093\/nar\/gkp599","volume":"37","author":"S Maas","year":"2009","unstructured":"Maas, S. & Gommans, W. M. Identification of a selective nuclear import signal in adenosine deaminases acting on RNA. Nucleic Acids Res. 37, 5822\u20135829 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR22","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1128\/MCB.01519-08","volume":"29","author":"J Fritz","year":"2009","unstructured":"Fritz, J. et al. RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1. Mol. Cell. Biol. 29, 1487\u20131497 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"1927_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nsmb.3203","volume":"23","author":"MM Matthews","year":"2016","unstructured":"Matthews, M. M. et al. Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat. Struct. Mol. Biol. 23, 426\u2013433 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1927_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature24041","volume":"550","author":"MH Tan","year":"2017","unstructured":"Tan, M. H. et al. Dynamic landscape and regulation of RNA editing in mammals. Nature 550, 249\u2013254 (2017).","journal-title":"Nature"},{"key":"1927_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nbt.2122","volume":"30","author":"Z Peng","year":"2012","unstructured":"Peng, Z. et al. Comprehensive analysis of RNA-seq data reveals extensive RNA editing in a human transcriptome. Nat. Biotechnol. 30, 253\u2013260 (2012).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1101\/gr.164749.113","volume":"24","author":"L Bazak","year":"2014","unstructured":"Bazak, L. et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res. 24, 365\u2013376 (2014).","journal-title":"Genome Res."},{"key":"1927_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nbt996","volume":"22","author":"EY Levanon","year":"2004","unstructured":"Levanon, E. Y. et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22, 1001\u20131005 (2004).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.immuni.2021.08.011","volume":"54","author":"Q Tang","year":"2021","unstructured":"Tang, Q. et al. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses. Immunity 54, 1961\u20131975 (2021).","journal-title":"Immunity"},{"key":"1927_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.aac7049","volume":"349","author":"BJ Liddicoat","year":"2015","unstructured":"Liddicoat, B. J. et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349, 1115\u20131120 (2015).","journal-title":"Science"},{"key":"1927_CR30","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.immuni.2021.07.001","volume":"54","author":"M Maurano","year":"2021","unstructured":"Maurano, M. et al. Protein kinase R and the integrated stress response drive immunopathology caused by mutations in the RNA deaminase ADAR1. Immunity 54, 1948\u20131960 (2021).","journal-title":"Immunity"},{"key":"1927_CR31","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","volume":"9","author":"NiamhM Mannion","year":"2014","unstructured":"Mannion, NiamhM. et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 9, 1482\u20131494 (2014).","journal-title":"Cell Rep."},{"key":"1927_CR32","doi-asserted-by":"crossref","unstructured":"de Reuver, R. et al. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation. Nature 607, 784\u2013789 (2022).","DOI":"10.1038\/s41586-022-04974-w"},{"key":"1927_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41576-018-0006-1","volume":"19","author":"E Eisenberg","year":"2018","unstructured":"Eisenberg, E. & Levanon, E. Y. A-to-I RNA editing \u2014 immune protector and transcriptome diversifier. Nat. Rev. Genet. 19, 473\u2013490 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"1927_CR34","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.7992055","volume":"266","author":"H Lomeli","year":"1994","unstructured":"Lomeli, H. et al. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266, 1709\u20131713 (1994).","journal-title":"Science"},{"key":"1927_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(91)90568-J","volume":"67","author":"B Sommer","year":"1991","unstructured":"Sommer, B., K\u00f6hler, M., Sprengel, R. & Seeburg, P. H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11\u201319 (1991).","journal-title":"Cell"},{"key":"1927_CR36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/0092-8674(93)90622-W","volume":"75","author":"M Higuchi","year":"1993","unstructured":"Higuchi, M. et al. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron\u2013exon structure determines position and efficiency. Cell 75, 1361\u20131370 (1993).","journal-title":"Cell"},{"key":"1927_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cell.2010.09.026","volume":"143","author":"R Stefl","year":"2010","unstructured":"Stefl, R. et al. The solution structure of the ADAR2 dsRBM\u2013RNA complex reveals a sequence-specific readout of the minor groove. Cell 143, 225\u2013237 (2010).","journal-title":"Cell"},{"key":"1927_CR38","doi-asserted-by":"publisher","first-page":"1600187","DOI":"10.1002\/bies.201600187","volume":"39","author":"JM Thomas","year":"2017","unstructured":"Thomas, J. M. & Beal, P. A. How do ADARs bind RNA? New protein\u2013RNA structures illuminate substrate recognition by the RNA editing ADARs. BioEssays 39, 1600187 (2017).","journal-title":"BioEssays"},{"key":"1927_CR39","doi-asserted-by":"crossref","unstructured":"Thuy-Boun, A. S. et al. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition. Nucleic Acids Res. 48, 7958\u20137972 (2020).","DOI":"10.1093\/nar\/gkaa532"},{"key":"1927_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41594-020-0398-4","volume":"27","author":"Y Song","year":"2020","unstructured":"Song, Y. et al. irCLASH reveals RNA substrates recognized by human ADARs. Nat. Struct. Mol. Biol. 27, 351\u2013362 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1927_CR41","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.1113150","volume":"309","author":"MR Macbeth","year":"2005","unstructured":"Macbeth, M. R. et al. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 309, 1534\u20131539 (2005).","journal-title":"Science"},{"key":"1927_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22489-2","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Learning cis-regulatory principles of ADAR-based RNA editing from CRISPR-mediated mutagenesis. Nat. Commun. 12, 2165 (2021).","journal-title":"Nat. Commun."},{"key":"1927_CR43","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1126\/science.284.5421.1841","volume":"284","author":"T Schwartz","year":"1999","unstructured":"Schwartz, T., Rould, M. A., Lowenhaupt, K., Herbert, A. & Rich, A. Crystal structure of the Z\u03b1 domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. Science 284, 1841\u20131845 (1999).","journal-title":"Science"},{"key":"1927_CR44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.str.2007.03.001","volume":"15","author":"D Placido","year":"2007","unstructured":"Placido, D., Brown, B. A., Lowenhaupt, K., Rich, A. & Athanasiadis, A. A left-handed RNA double helix bound by the Z\u03b1 domain of the RNA-editing enzyme ADAR1. Structure 15, 395\u2013404 (2007).","journal-title":"Structure"},{"key":"1927_CR45","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/nar\/gkn976","volume":"37","author":"SC Ha","year":"2009","unstructured":"Ha, S. C. et al. The structures of non-CG-repeat Z-DNAs co-crystallized with the Z-DNA-binding domain, hZ\u03b1 ADAR1. Nucleic Acids Res. 37, 629\u2013637 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR46","doi-asserted-by":"publisher","first-page":"20550","DOI":"10.1016\/S0021-9258(18)54960-7","volume":"266","author":"PP Lau","year":"1991","unstructured":"Lau, P. P., Xiong, W. J., Zhu, H. J., Chen, S. H. & Chan, L. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J. Biol. Chem. 266, 20550\u201320554 (1991).","journal-title":"J. Biol. Chem."},{"key":"1927_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7881","volume":"6","author":"S Sharma","year":"2015","unstructured":"Sharma, S. et al. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages. Nat. Commun. 6, 6881 (2015).","journal-title":"Nat. Commun."},{"key":"1927_CR48","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.8511591","volume":"260","author":"B Teng","year":"1993","unstructured":"Teng, B., Burant Charles, F. & Davidson Nicholas, O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816\u20131819 (1993).","journal-title":"Science"},{"key":"1927_CR49","doi-asserted-by":"publisher","first-page":"903","DOI":"10.15252\/embr.201438450","volume":"15","author":"N Fossat","year":"2014","unstructured":"Fossat, N. et al. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47. EMBO Rep. 15, 903\u2013910 (2014).","journal-title":"EMBO Rep."},{"key":"1927_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1261\/rna.068395.118","volume":"25","author":"V Blanc","year":"2019","unstructured":"Blanc, V. et al. APOBEC1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver. RNA 25, 70\u201381 (2019).","journal-title":"RNA"},{"key":"1927_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1261\/rna.058818.116","volume":"23","author":"EM Snyder","year":"2017","unstructured":"Snyder, E. M. et al. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo. RNA 23, 457\u2013465 (2017).","journal-title":"RNA"},{"key":"1927_CR52","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1128\/MCB.18.8.4426","volume":"18","author":"A Mehta","year":"1998","unstructured":"Mehta, A. & Driscoll Donna, M. A sequence-specific RNA-binding protein complements APOBEC-1 to edit apolipoprotein B mRNA. Mol. Cell. Biol. 18, 4426\u20134432 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"1927_CR53","doi-asserted-by":"publisher","first-page":"16301","DOI":"10.1016\/S0021-9258(18)55296-0","volume":"266","author":"RR Shah","year":"1991","unstructured":"Shah, R. R. et al. Sequence requirements for the editing of apolipoprotein B mRNA. J. Biol. Chem. 266, 16301\u201316304 (1991).","journal-title":"J. Biol. Chem."},{"key":"1927_CR54","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"1927_CR55","doi-asserted-by":"publisher","first-page":"e108209","DOI":"10.15252\/embj.2021108209","volume":"40","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. Programmable C-to-U RNA editing using the human APOBEC3A deaminase. EMBO J. 40, e108209 (2021).","journal-title":"EMBO J."},{"key":"1927_CR56","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770\u2013788 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"1927_CR57","doi-asserted-by":"crossref","unstructured":"Khosravi, H. M. & Jantsch, M. F. Site-directed RNA editing: recent advances and open challenges. RNA Biol. 18, 41\u201350 (2021).","DOI":"10.1080\/15476286.2021.1983288"},{"key":"1927_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymeth.2018.11.016","volume":"156","author":"MF Montiel-Gonzalez","year":"2019","unstructured":"Montiel-Gonzalez, M. F., Diaz Quiroz, J. F. & Rosenthal, J. J. C. Current strategies for site-directed RNA editing using ADARs. Methods 156, 16\u201324 (2019).","journal-title":"Methods"},{"key":"1927_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.copbio.2018.08.006","volume":"55","author":"P Vogel","year":"2019","unstructured":"Vogel, P. & Stafforst, T. Critical review on engineering deaminases for site-directed RNA editing. Curr. Opin. Biotechnol. 55, 74\u201380 (2019).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1927_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1324","volume":"2","author":"JM Eggington","year":"2011","unstructured":"Eggington, J. M., Greene, T. & Bass, B. L. Predicting sites of ADAR editing in double-stranded RNA. Nat. Commun. 2, 319 (2011).","journal-title":"Nat. Commun."},{"key":"1927_CR61","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1002\/j.1460-2075.1994.tb06908.x","volume":"13","author":"AG Polson","year":"1994","unstructured":"Polson, A. G. & Bass, B. L. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J. 13, 5701\u20135711 (1994).","journal-title":"EMBO J."},{"key":"1927_CR62","doi-asserted-by":"crossref","unstructured":"Doherty, E. E. et al. ADAR activation by inducing a syn conformation at guanosine adjacent to an editing site. Nucleic Acids Res. 50, 10857\u201310868 (2022).","DOI":"10.1093\/nar\/gkac897"},{"key":"1927_CR63","doi-asserted-by":"publisher","first-page":"E3295\u20133304","DOI":"10.1073\/pnas.1212548109","volume":"109","author":"A Kuttan","year":"2012","unstructured":"Kuttan, A. & Bass, B. L. Mechanistic insights into editing-site specificity of ADARs. Proc. Natl Acad. Sci. USA 109, E3295\u20133304 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR64","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41592-018-0017-z","volume":"15","author":"P Vogel","year":"2018","unstructured":"Vogel, P. et al. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs. Nat. Methods 15, 535\u2013538 (2018).","journal-title":"Nat. Methods"},{"key":"1927_CR65","doi-asserted-by":"crossref","unstructured":"Buchumenski, I. et al. Global quantification exposes abundant low-level off-target activity by base editors. Genome Res. 31, 2354\u20132361 (2021).","DOI":"10.1101\/gr.275770.121"},{"key":"1927_CR66","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1017\/S135583820101007X","volume":"7","author":"SK Wong","year":"2001","unstructured":"Wong, S. K., Sato, S. & Lazinski, D. W. Substrate recognition by ADAR1 and ADAR2. RNA 7, 846\u2013858 (2001).","journal-title":"RNA"},{"key":"1927_CR67","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1093\/nar\/gku272","volume":"42","author":"MF Schneider","year":"2014","unstructured":"Schneider, M. F., Wettengel, J., Hoffmann, P. C. & Stafforst, T. Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans. Nucleic Acids Res. 42, e87 (2014).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR68","doi-asserted-by":"crossref","unstructured":"Diaz Quiroz, J. F. et al. Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing. Nucleic Acids Res. 51, e41 (2023).","DOI":"10.1093\/nar\/gkad098"},{"key":"1927_CR69","doi-asserted-by":"crossref","unstructured":"Uzonyi, A. et al. Deciphering the principles of the RNA editing code via large-scale systematic probing. Mol. Cell 81, 2374\u20132387 (2021).","DOI":"10.1016\/j.molcel.2021.03.024"},{"key":"1927_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23576-0","volume":"12","author":"X Xiang","year":"2021","unstructured":"Xiang, X. et al. Enhancing CRISPR\u2013Cas9 gRNA efficiency prediction by data integration and deep learning. Nat. Commun. 12, 3238 (2021).","journal-title":"Nat. Commun."},{"key":"1927_CR71","first-page":"223","volume":"21","author":"AH Muhammad Rafid","year":"2020","unstructured":"Muhammad Rafid, A. H., Toufikuzzaman, M., Rahman, M. S. & Rahman, M. S. CRISPRpred(SEQ): a sequence-based method for sgRNA on target activity prediction using traditional machine learning. BMC Bioinformatics 21, 223 (2020).","journal-title":"BMC"},{"key":"1927_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/15476286.2019.1669406","volume":"17","author":"J Wang","year":"2020","unstructured":"Wang, J., Zhang, X., Cheng, L. & Luo, Y. An overview and metanalysis of machine and deep learning-based CRISPR gRNA design tools. RNA Biol. 17, 13\u201322 (2020).","journal-title":"RNA Biol."},{"key":"1927_CR73","volume":"19","author":"Y Han","year":"2018","unstructured":"Han, Y., He, F., Chen, Y., Liu, Y. & Yu, H. siRNA silencing efficacy prediction based on a deep architecture. BMC Genomics 19, 669 (2018).","journal-title":"BMC"},{"key":"1927_CR74","doi-asserted-by":"crossref","unstructured":"Han, Y., He, F., Tan, X. & Yu, H. In 2017 IEEE International Conference on Bioinformatics and Biomedicine 16\u201321 (IEEE, 2017).","DOI":"10.1109\/BIBM.2017.8217618"},{"key":"1927_CR75","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41587-019-0013-6","volume":"37","author":"T Merkle","year":"2019","unstructured":"Merkle, T. et al. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat. Biotechnol. 37, 133\u2013138 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR76","doi-asserted-by":"publisher","first-page":"8735","DOI":"10.1016\/S0040-4039(97)10322-7","volume":"38","author":"S Obika","year":"1997","unstructured":"Obika, S. et al. Synthesis of 2\u2032-O,4\u2032-C-methyleneuridine and -cytidine. Novel bicyclic nucleosides having a fixed C3, -endo sugar puckering. Tetrahedron Lett. 38, 8735\u20138738 (1997).","journal-title":"Tetrahedron Lett."},{"key":"1927_CR77","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1016\/S0040-4020(98)00094-5","volume":"54","author":"AA Koshkin","year":"1998","unstructured":"Koshkin, A. A. et al. LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron 54, 3607\u20133630 (1998).","journal-title":"Tetrahedron"},{"key":"1927_CR78","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1002\/anie.201402634","volume":"53","author":"P Vogel","year":"2014","unstructured":"Vogel, P., Schneider, M. F., Wettengel, J. & Stafforst, T. Improving site-directed RNA editing in vitro and in cell culture by chemical modification of the guideRNA. Angew. Chem. Int. Ed. Engl. 53, 6267\u20136271 (2014).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1927_CR79","doi-asserted-by":"crossref","unstructured":"Monian, P. et al. Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides. Nat. Biotechnol. 40, 1093\u20131102 (2022).","DOI":"10.1038\/s41587-022-01225-1"},{"key":"1927_CR80","doi-asserted-by":"crossref","unstructured":"Doherty, E. E. et al. Rational design of RNA editing guide strands: cytidine analogs at the orphan position. J. Am. Chem. Soc. 143, 6865\u20136876 (2021).","DOI":"10.1021\/jacs.0c13319"},{"key":"1927_CR81","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1101\/gr.162339.113","volume":"24","author":"SW Cho","year":"2014","unstructured":"Cho, S. W. et al. Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases. Genome Res. 24, 132\u2013141 (2014).","journal-title":"Genome Res."},{"key":"1927_CR82","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-019-1314-0","volume":"571","author":"C Zhou","year":"2019","unstructured":"Zhou, C. et al. Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis. Nature 571, 275\u2013278 (2019).","journal-title":"Nature"},{"key":"1927_CR83","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/19992","volume":"399","author":"SM Rueter","year":"1999","unstructured":"Rueter, S. M., Dawson, T. R. & Emeson, R. B. Regulation of alternative splicing by RNA editing. Nature 399, 75\u201380 (1999).","journal-title":"Nature"},{"key":"1927_CR84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/nar\/gky1163","volume":"47","author":"K Licht","year":"2019","unstructured":"Licht, K. et al. Inosine induces context-dependent recoding and translational stalling. Nucleic Acids Res. 47, 3\u201314 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR85","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1021\/acssynbio.7b00113","volume":"6","author":"P Vogel","year":"2017","unstructured":"Vogel, P., Hanswillemenke, A. & Stafforst, T. Switching protein localization by site-directed RNA editing under control of light. ACS Synth. Biol. 6, 1642\u20131649 (2017).","journal-title":"ACS Synth. Biol."},{"key":"1927_CR86","doi-asserted-by":"publisher","first-page":"269\u2013277","DOI":"10.1016\/j.chembiol.2018.10.025","volume":"26","author":"LR Monteleone","year":"2019","unstructured":"Monteleone, L. R. et al. A bump\u2013hole approach for directed RNA editing. Cell Chem. Biol. 26, 269\u2013277 (2019).","journal-title":"Cell Chem. Biol."},{"key":"1927_CR87","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1126\/science.aax7063","volume":"365","author":"O Abudayyeh Omar","year":"2019","unstructured":"Abudayyeh Omar, O. et al. A cytosine deaminase for programmable single-base RNA editing. Science 365, 382\u2013386 (2019).","journal-title":"Science"},{"key":"1927_CR88","doi-asserted-by":"publisher","first-page":"1019\u20131027","DOI":"10.1126\/science.aaq0180","volume":"358","author":"DBT Cox","year":"2017","unstructured":"Cox, D. B. T. et al. RNA editing with CRISPR\u2013Cas13. Science 358, 1019\u20131027 (2017).","journal-title":"Science"},{"key":"1927_CR89","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/15476286.2017.1387711","volume":"15","author":"IC Vallecillo-Viejo","year":"2018","unstructured":"Vallecillo-Viejo, I. C., Liscovitch-Brauer, N., Montiel-Gonzalez, M. F., Eisenberg, E. & Rosenthal, J. J. C. Abundant off-target edits from site-directed RNA editing can be reduced by nuclear localization of the editing enzyme. RNA Biol. 15, 104\u2013114 (2018).","journal-title":"RNA Biol."},{"key":"1927_CR90","doi-asserted-by":"publisher","first-page":"e75555","DOI":"10.7554\/eLife.75555","volume":"11","author":"D Katrekar","year":"2022","unstructured":"Katrekar, D. et al. Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity. eLife 11, e75555 (2022).","journal-title":"eLife"},{"key":"1927_CR91","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41592-019-0323-0","volume":"16","author":"D Katrekar","year":"2019","unstructured":"Katrekar, D. et al. In vivo RNA editing of point mutations via RNA-guided adenosine deaminases. Nat. Methods 16, 239\u2013242 (2019).","journal-title":"Nat. Methods"},{"key":"1927_CR92","doi-asserted-by":"publisher","first-page":"15875","DOI":"10.1021\/jacs.5b10216","volume":"137","author":"A Hanswillemenke","year":"2015","unstructured":"Hanswillemenke, A., Kuzdere, T., Vogel, P., Jekely, G. & Stafforst, T. Site-directed RNA editing in vivo can be triggered by the light-driven assembly of an artificial riboprotein. J. Am. Chem. Soc. 137, 15875\u201315881 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"1927_CR93","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.mie.2019.06.004","volume":"624","author":"A Hanswillemenke","year":"2019","unstructured":"Hanswillemenke, A. & Stafforst, T. Protocols for the generation of caged guideRNAs for light-triggered RNA-targeting with SNAP\u2013ADARs. Methods Enzymol. 624, 47\u201368 (2019).","journal-title":"Methods Enzymol."},{"key":"1927_CR94","doi-asserted-by":"publisher","first-page":"12300","DOI":"10.1002\/chem.202101985","volume":"27","author":"AS Stroppel","year":"2021","unstructured":"Stroppel, A. S., Lappalainen, R. & Stafforst, T. Controlling site-directed RNA editing by chemically induced dimerization. Chemistry 27, 12300\u201312304 (2021).","journal-title":"Chemistry"},{"key":"1927_CR95","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1021\/acscentsci.0c00537","volume":"6","author":"S Rauch","year":"2020","unstructured":"Rauch, S., Jones, K. A. & Dickinson, B. C. Small molecule-inducible RNA-targeting systems for temporal control of RNA regulation. ACS Cent. Sci. 6, 1987\u20131996 (2020).","journal-title":"ACS Cent. Sci."},{"key":"1927_CR96","doi-asserted-by":"publisher","first-page":"E9395\u2013E9402","DOI":"10.1073\/pnas.1715320114","volume":"114","author":"JR Sinnamon","year":"2017","unstructured":"Sinnamon, J. R. et al. Site-directed RNA repair of endogenous Mecp2 RNA in neurons. Proc. Natl Acad. Sci. USA 114, E9395\u2013E9402 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR97","doi-asserted-by":"publisher","first-page":"e2206053119","DOI":"10.1073\/pnas.2206053119","volume":"119","author":"JR Sinnamon","year":"2022","unstructured":"Sinnamon, J. R. et al. Targeted RNA editing in brainstem alleviates respiratory dysfunction in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 119, e2206053119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR98","doi-asserted-by":"publisher","first-page":"107878","DOI":"10.1016\/j.celrep.2020.107878","volume":"32","author":"JR Sinnamon","year":"2020","unstructured":"Sinnamon, J. R. et al. In vivo repair of a protein underlying a neurological disorder by programmable RNA editing. Cell Rep. 32, 107878 (2020).","journal-title":"Cell Rep."},{"key":"1927_CR99","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1927_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15892-8","volume":"11","author":"T Jiang","year":"2020","unstructured":"Jiang, T. et al. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nat. Commun. 11, 1979 (2020).","journal-title":"Nat. Commun."},{"key":"1927_CR101","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Kariko","year":"2005","unstructured":"Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165\u2013175 (2005).","journal-title":"Immunity"},{"key":"1927_CR102","first-page":"111","volume":"19","author":"A Judge","year":"2008","unstructured":"Judge, A. & MacLachlan, I. Overcoming the innate immune response to small interfering RNA. Hum. Gene Ther. 19, 111\u2013124 (2008).","journal-title":"Hum."},{"key":"1927_CR103","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1101\/gr.231936.117","volume":"28","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 28, 367\u2013373 (2018).","journal-title":"Genome Res."},{"key":"1927_CR104","doi-asserted-by":"publisher","first-page":"11166","DOI":"10.1002\/anie.201206489","volume":"51","author":"T Stafforst","year":"2012","unstructured":"Stafforst, T. & Schneider, M. F. An RNA\u2013deaminase conjugate selectively repairs point mutations. Angew. Chem. Int. Ed. Engl. 51, 11166\u201311169 (2012).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1927_CR105","doi-asserted-by":"publisher","first-page":"18285\u201318290","DOI":"10.1073\/pnas.1306243110","volume":"110","author":"MF Montiel-Gonzalez","year":"2013","unstructured":"Montiel-Gonzalez, M. F., Vallecillo-Viejo, I., Yudowski, G. A. & Rosenthal, J. J. C. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc. Natl Acad. Sci. USA 110, 18285\u201318290 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR106","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nbt765","volume":"21","author":"A Keppler","year":"2003","unstructured":"Keppler, A. et al. A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat. Biotechnol. 21, 86\u201389 (2003).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR107","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.ge.22.120188.000453","volume":"22","author":"NL Craig","year":"1988","unstructured":"Craig, N. L. The mechanism of conservative site-specific recombination. Annu. Rev. Genet. 22, 77\u2013105 (1988).","journal-title":"Annu. Rev. Genet."},{"key":"1927_CR108","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0958-1669(94)90068-X","volume":"5","author":"B Sauer","year":"1994","unstructured":"Sauer, B. Site-specific recombination: developments and applications. Curr. Opin. Biotechnol. 5, 521\u2013527 (1994).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1927_CR109","doi-asserted-by":"crossref","unstructured":"Stroppel, A. S. et al. Harnessing self-labeling enzymes for selective and concurrent A-to-I and C-to-U RNA base editing. Nucleic Acids Res. 49, e95 (2021).","DOI":"10.1093\/nar\/gkab541"},{"key":"1927_CR110","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1093\/nar\/gkad598","volume":"51","author":"N Latifi","year":"2023","unstructured":"Latifi, N., Mack, A. M., Tellioglu, I., Di Giorgio, S. & Stafforst, T. Precise and efficient C-to-U RNA base editing with SNAP-CDAR-S. Nucleic Acids Res. 51, e84 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR111","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1021\/cb800025k","volume":"3","author":"GV Los","year":"2008","unstructured":"Los, G. V. et al. HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem. Biol. 3, 373\u2013382 (2008).","journal-title":"ACS Chem. Biol."},{"key":"1927_CR112","doi-asserted-by":"publisher","first-page":"4061\u20134065","DOI":"10.1073\/pnas.92.9.4061","volume":"92","author":"S Chattopadhyay","year":"1995","unstructured":"Chattopadhyay, S., Garcia-Mena, J., DeVito, J., Wolska, K. & Das, A. Bipartite function of a small RNA hairpin in transcription antitermination in bacteriophage lambda. Proc. Natl Acad. Sci. USA 92, 4061\u20134065 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR113","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1021\/ja026610b","volume":"124","author":"RJ Austin","year":"2002","unstructured":"Austin, R. J., Xia, T., Ren, J., Takahashi, T. T. & Roberts, R. W. Designed arginine-rich RNA-binding peptides with picomolar affinity. J. Am. Chem. Soc. 124, 10966\u201310967 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"1927_CR114","first-page":"e157","volume":"44","author":"MF Montiel-Gonz\u00e1lez","year":"2016","unstructured":"Montiel-Gonz\u00e1lez, M. F., Vallecillo-Viejo, I. C. & Rosenthal, JoshuaJ. C. An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res. 44, e157 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR115","first-page":"779","volume":"24","author":"MTA Azad","year":"2017","unstructured":"Azad, M. T. A., Bhakta, S. & Tsukahara, T. Site-directed RNA editing by adenosine deaminase acting on RNA for correction of the genetic code in gene therapy. Gene Ther. 24, 779\u2013786 (2017).","journal-title":"Gene"},{"key":"1927_CR116","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/protein\/gzz005","volume":"31","author":"S Bhakta","year":"2018","unstructured":"Bhakta, S., Azad, M. T. A. & Tsukahara, T. Genetic code restoration by artificial RNA editing of ochre stop codon with ADAR1 deaminase. Protein Eng. Des. Sel. 31, 471\u2013478 (2018).","journal-title":"Protein Eng. Des."},{"key":"1927_CR117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nmeth.4502","volume":"15","author":"E Tutucci","year":"2018","unstructured":"Tutucci, E. et al. An improved MS2 system for accurate reporting of the mRNA life cycle. Nat. Methods 15, 81\u201389 (2018).","journal-title":"Nat. Methods"},{"key":"1927_CR118","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1006\/jmbi.1997.1144","volume":"270","author":"K Valeg\u00e5rd","year":"1997","unstructured":"Valeg\u00e5rd, K. et al. The three-dimensional structures of two complexes between recombinant MS2 capsids and RNA operator fragments reveal sequence-specific protein\u2013RNA interactions. J. Mol. Biol. 270, 724\u2013738 (1997).","journal-title":"J. Mol. Biol."},{"key":"1927_CR119","doi-asserted-by":"publisher","first-page":"109851","DOI":"10.1016\/j.enzmictec.2021.109851","volume":"149","author":"S Bhakta","year":"2021","unstructured":"Bhakta, S. & Tsukahara, T. Double MS2 guided restoration of genetic code in amber (TAG), opal (TGA) and ochre (TAA) stop codon. Enzyme Microb. Technol. 149, 109851 (2021).","journal-title":"Enzyme Microb. Technol."},{"key":"1927_CR120","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cell.2019.05.049","volume":"178","author":"S Rauch","year":"2019","unstructured":"Rauch, S. et al. Programmable RNA-guided RNA effector proteins built from human parts. Cell 178, 122\u2013134 (2019).","journal-title":"Cell"},{"key":"1927_CR121","doi-asserted-by":"publisher","first-page":"108350","DOI":"10.1016\/j.celrep.2020.108350","volume":"33","author":"RJ Marina","year":"2020","unstructured":"Marina, R. J., Brannan, K. W., Dong, K. D., Yee, B. A. & Yeo, G. W. Evaluation of engineered CRISPR\u2013Cas-mediated systems for site-specific RNA editing. Cell Rep. 33, 108350 (2020).","journal-title":"Cell Rep."},{"key":"1927_CR122","doi-asserted-by":"publisher","first-page":"e4136","DOI":"10.7717\/peerj.4136","volume":"5","author":"S Sharma","year":"2017","unstructured":"Sharma, S. & Baysal, B. E. Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G. PeerJ 5, e4136 (2017).","journal-title":"PeerJ"},{"key":"1927_CR123","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1021\/acssynbio.0c00627","volume":"10","author":"G Tang","year":"2021","unstructured":"Tang, G. et al. Creating RNA specific C-to-U editase from APOBEC3A by separation of its activities on DNA and RNA substrates. ACS Synth. Biol. 10, 1106\u20131115 (2021).","journal-title":"ACS Synth. Biol."},{"key":"1927_CR124","doi-asserted-by":"crossref","unstructured":"Kannan, S. et al. Compact RNA editors with small Cas13 proteins. Nat. Biotechnol. 40, 194\u2013197 (2021).","DOI":"10.1038\/s41587-021-01030-2"},{"key":"1927_CR125","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41592-021-01124-4","volume":"18","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. Programmable RNA editing with compact CRISPR\u2013Cas13 systems from uncultivated microbes. Nat. Methods 18, 499\u2013506 (2021).","journal-title":"Nat. Methods"},{"key":"1927_CR126","doi-asserted-by":"crossref","unstructured":"Xiao, Q. et al. Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor. Sci. Transl. Med. 14, eabn0449 (2022).","DOI":"10.1126\/scitranslmed.abn0449"},{"key":"1927_CR127","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med."},{"key":"1927_CR128","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","volume":"28","author":"A Li","year":"2020","unstructured":"Li, A. et al. AAV\u2013CRISPR gene editing is negated by pre-existing immunity to Cas9. Mol. Ther. 28, 1432\u20131441 (2020).","journal-title":"Mol. Ther."},{"key":"1927_CR129","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","volume":"25","author":"DL Wagner","year":"2019","unstructured":"Wagner, D. L. et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat. Med. 25, 242\u2013248 (2019).","journal-title":"Nat. Med."},{"key":"1927_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26830-7","volume":"12","author":"CH Hakim","year":"2021","unstructured":"Hakim, C. H. et al. Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models. Nat. Commun. 12, 6769 (2021).","journal-title":"Nat. Commun."},{"key":"1927_CR131","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","volume":"10","author":"VL Simhadri","year":"2018","unstructured":"Simhadri, V. L. et al. Prevalence of pre-existing antibodies to CRISPR-associated nuclease Cas9 in the USA population. Mol. Ther. Methods Clin. Dev. 10, 105\u2013112 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1927_CR132","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. & Taipale, J. CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response. Nat. Med. 24, 927\u2013930 (2018).","journal-title":"Nat. Med."},{"key":"1927_CR133","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ Ihry","year":"2018","unstructured":"Ihry, R. J. et al. p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells. Nat. Med. 24, 939\u2013946 (2018).","journal-title":"Nat. Med."},{"key":"1927_CR134","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41588-020-0623-4","volume":"52","author":"OM Enache","year":"2020","unstructured":"Enache, O. M. et al. Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nat. Genet. 52, 662\u2013668 (2020).","journal-title":"Nat. Genet."},{"key":"1927_CR135","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/s41591-022-01848-6","volume":"28","author":"X-ZE Tang","year":"2022","unstructured":"Tang, X.-Z. E., Tan, S. X., Hoon, S. & Yeo, G. W. Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans. Nat. Med. 28, 1372\u20131376 (2022).","journal-title":"Nat. Med."},{"key":"1927_CR136","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.chembiol.2019.02.005","volume":"26","author":"T Stafforst","year":"2019","unstructured":"Stafforst, T. Chemistry helps to bump off-target edits away. Cell Chem. Biol. 26, 151\u2013152 (2019).","journal-title":"Cell Chem. Biol."},{"key":"1927_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25433-6","volume":"12","author":"W Zhou","year":"2021","unstructured":"Zhou, W. et al. Expanding the binding specificity for RNA recognition by a PUF domain. Nat. Commun. 12, 5107 (2021).","journal-title":"Nat. Commun."},{"key":"1927_CR138","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nchembio.577","volume":"7","author":"A Filipovska","year":"2011","unstructured":"Filipovska, A., Razif, M. F. M., Nyg\u00e5rd, K. K. A. & Rackham, O. A universal code for RNA recognition by PUF proteins. Nat. Chem. Biol. 7, 425\u2013427 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"1927_CR139","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1093\/nar\/gkac713","volume":"50","author":"W Han","year":"2022","unstructured":"Han, W. et al. Programmable RNA base editing with a single gRNA-free enzyme. Nucleic Acids Res. 50, 9580\u20139595 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR140","doi-asserted-by":"crossref","unstructured":"Reautschnig, P. et al. CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo. Nat. Biotechnol. 40, 759\u2013768 (2022).","DOI":"10.1038\/s41587-021-01105-0"},{"key":"1927_CR141","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41587-019-0178-z","volume":"37","author":"L Qu","year":"2019","unstructured":"Qu, L. et al. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat. Biotechnol. 37, 1059\u20131069 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02271-9","volume":"22","author":"V Tassinari","year":"2021","unstructured":"Tassinari, V. et al. ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism. Genome Biol. 22, 51 (2021).","journal-title":"Genome Biol."},{"key":"1927_CR143","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood-2018-02-832576","volume":"132","author":"PJ Teoh","year":"2018","unstructured":"Teoh, P. J. et al. Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood 132, 1304\u20131317 (2018).","journal-title":"Blood"},{"key":"1927_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01299-8","volume":"20","author":"J Behroozi","year":"2020","unstructured":"Behroozi, J., Shahbazi, S., Bakhtiarizadeh, M. R. & Mahmoodzadeh, H. ADAR expression and copy number variation in patients with advanced gastric cancer. BMC Gastroenterol. 20, 152 (2020).","journal-title":"BMC Gastroenterol."},{"key":"1927_CR145","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2016.06.043","volume":"151","author":"THM Chan","year":"2016","unstructured":"Chan, T. H. M. et al. ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer. Gastroenterology 151, 637\u2013650 (2016).","journal-title":"Gastroenterology"},{"key":"1927_CR146","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trecan.2019.03.004","volume":"5","author":"A Herbert","year":"2019","unstructured":"Herbert, A. ADAR and immune silencing in cancer. Trends Cancer 5, 272\u2013282 (2019).","journal-title":"Trends Cancer"},{"key":"1927_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01377-9","volume":"11","author":"N Salvetat","year":"2021","unstructured":"Salvetat, N. et al. Phosphodiesterase 8A to discriminate in blood samples depressed patients and suicide attempters from healthy controls based on A-to-I RNA editing modifications. Transl. Psychiatry 11, 255 (2021).","journal-title":"Transl. Psychiatry"},{"key":"1927_CR148","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41593-019-0463-7","volume":"22","author":"MS Breen","year":"2019","unstructured":"Breen, M. S. et al. Global landscape and genetic regulation of RNA editing in cortical samples from individuals with schizophrenia. Nat. Neurosci. 22, 1402\u20131412 (2019).","journal-title":"Nat. Neurosci."},{"key":"1927_CR149","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/genes11080872","volume":"11","author":"A Barbon","year":"2020","unstructured":"Barbon, A. & Magri, C. RNA editing and modifications in mood disorders. Genes 11, 872 (2020).","journal-title":"Genes"},{"key":"1927_CR150","doi-asserted-by":"publisher","first-page":"11870","DOI":"10.3390\/ijms222111870","volume":"22","author":"B Chatterjee","year":"2021","unstructured":"Chatterjee, B., Shen, C. J. & Majumder, P. RNA modifications and RNA metabolism in neurological disease pathogenesis. Int. J. Mol. Sci. 22, 11870 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1927_CR151","doi-asserted-by":"crossref","unstructured":"Yi, Z. et al. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat. Biotechnol. 40, 946\u2013955 (2022).","DOI":"10.1038\/s41587-021-01180-3"},{"key":"1927_CR152","doi-asserted-by":"crossref","unstructured":"Katrekar, D. et al. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat. Biotechnol. 40, 938\u2013945 (2022).","DOI":"10.1038\/s41587-021-01171-4"},{"key":"1927_CR153","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41587-019-0090-6","volume":"37","author":"JL Litke","year":"2019","unstructured":"Litke, J. L. & Jaffrey, S. R. Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. Nat. Biotechnol. 37, 667\u2013675 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jmbi.1999.2914","volume":"291","author":"KA Lehmann","year":"1999","unstructured":"Lehmann, K. A. & Bass, B. L. The importance of internal loops within RNA substrates of ADAR1. J. Mol. Biol. 291, 1\u201313 (1999).","journal-title":"J. Mol. Biol."},{"key":"1927_CR155","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","volume":"99","author":"D Wang","year":"2010","unstructured":"Wang, D. et al. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation. Mol. Genet. Metab. 99, 62\u201371 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"1927_CR156","first-page":"2797","volume":"45","author":"J Wettengel","year":"2016","unstructured":"Wettengel, J., Reautschnig, P., Geisler, S., Kahle, P. J. & Stafforst, T. Harnessing human ADAR2 for RNA repair\u2014recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res. 45, 2797\u20132808 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR157","doi-asserted-by":"publisher","first-page":"41478","DOI":"10.1038\/srep41478","volume":"7","author":"M Fukuda","year":"2017","unstructured":"Fukuda, M. et al. Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing. Sci. Rep. 7, 41478 (2017).","journal-title":"Sci. Rep."},{"key":"1927_CR158","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/genes8010034","volume":"8","author":"M Heep","year":"2017","unstructured":"Heep, M., Mach, P., Reautschnig, P., Wettengel, J. & Stafforst, T. Applying human ADAR1p110 and ADAR1p150 for site-directed RNA editing\u2014G\/C substitution stabilizes guideRNAs against editing. Genes 8, 34 (2017).","journal-title":"Genes"},{"key":"1927_CR159","doi-asserted-by":"crossref","unstructured":"Nose, K., Hidaka, K., Yano, T., Tomita, Y. & Fukuda, M. Short-chain guide RNA for site-directed A-to-I RNA editing. Nucleic Acid Ther. 31, 58\u201367 (2020).","DOI":"10.1089\/nat.2020.0866"},{"key":"1927_CR160","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.1074\/jbc.M210326200","volume":"278","author":"TA Vickers","year":"2003","unstructured":"Vickers, T. A. et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents: a comparative analysis. J. Biol. Chem. 278, 7108\u20137118 (2003).","journal-title":"J. Biol. Chem."},{"key":"1927_CR161","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/nar\/28.6.1340","volume":"28","author":"TA Vickers","year":"2000","unstructured":"Vickers, T. A., Wyatt, J. R. & Freier, S. M. Effects of RNA secondary structure on cellular antisense activity. Nucleic Acids Res. 28, 1340\u20131347 (2000).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR162","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/nar\/gkv1367","volume":"44","author":"Y Enuka","year":"2016","unstructured":"Enuka, Y. et al. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. Nucleic Acids Res. 44, 1370\u20131383 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR163","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","volume":"46","author":"X Shen","year":"2018","unstructured":"Shen, X. & Corey, D. R. Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucleic Acids Res. 46, 1584\u20131600 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR164","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke, S. T., Baker, B. F., Crooke, R. M. & Liang, X.-H. Antisense technology: an overview and prospectus. Nat. Rev. Drug Discov. 20, 427\u2013453 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1927_CR165","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1089\/nat.2018.0753","volume":"29","author":"ST Crooke","year":"2018","unstructured":"Crooke, S. T. et al. Integrated assessment of the clinical performance of GalNAc3-conjugated 2\u2032-O-methoxyethyl chimeric antisense oligonucleotides: I. Human volunteer experience. Nucleic Acid Ther. 29, 16\u201332 (2018).","journal-title":"Nucleic Acid"},{"key":"1927_CR166","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","volume":"388","author":"NJ Viney","year":"2016","unstructured":"Viney, N. J. et al. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. Lancet 388, 2239\u20132253 (2016).","journal-title":"Lancet"},{"key":"1927_CR167","doi-asserted-by":"publisher","first-page":"26801","DOI":"10.1016\/S0021-9258(18)47090-1","volume":"269","author":"DA Brown","year":"1994","unstructured":"Brown, D. A. et al. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269, 26801\u201326805 (1994).","journal-title":"J. Biol. Chem."},{"key":"1927_CR168","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0014-5793(95)00517-D","volume":"366","author":"DA Weidner","year":"1995","unstructured":"Weidner, D. A., Valdez, B. C., Henning, D., Greenberg, S. & Busch, H. Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23\/nucleolin. FEBS Lett. 366, 146\u2013150 (1995).","journal-title":"FEBS Lett."},{"key":"1927_CR169","doi-asserted-by":"publisher","first-page":"791416","DOI":"10.3389\/fgene.2022.791416","volume":"13","author":"LL Flynn","year":"2022","unstructured":"Flynn, L. L. et al. Single stranded fully modified-phosphorothioate oligonucleotides can induce structured nuclear inclusions, alter nuclear protein localization and disturb the transcriptome in vitro. Front. Genet. 13, 791416 (2022).","journal-title":"Front. Genet."},{"key":"1927_CR170","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1093\/nar\/gkaa299","volume":"48","author":"ST Crooke","year":"2020","unstructured":"Crooke, S. T., Vickers, T. A. & Liang, X.-H. Phosphorothioate modified oligonucleotide\u2013protein interactions. Nucleic Acids Res. 48, 5235\u20135253 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR171","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nbt.3802","volume":"35","author":"SF Dowdy","year":"2017","unstructured":"Dowdy, S. F. Overcoming cellular barriers for RNA therapeutics. Nat. Biotechnol. 35, 222\u2013229 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR172","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2019.11.001","volume":"179","author":"W Greulich","year":"2019","unstructured":"Greulich, W. et al. TLR8 is a sensor of RNase T2 degradation products. Cell 179, 1264\u20131275 (2019).","journal-title":"Cell"},{"key":"1927_CR173","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41587-019-0106-2","volume":"37","author":"W Shen","year":"2019","unstructured":"Shen, W. et al. Chemical modification of PS\u2013ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nat. Biotechnol. 37, 640\u2013650 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR174","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/genes10020092","volume":"10","author":"I Freund","year":"2019","unstructured":"Freund, I., Eigenbrod, T., Helm, M. & Dalpke, A. H. RNA modifications modulate activation of innate Toll-like receptors. Genes 10, 92 (2019).","journal-title":"Genes"},{"key":"1927_CR175","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/nar\/gkp841","volume":"38","author":"CA Stein","year":"2009","unstructured":"Stein, C. A. et al. Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res. 38, e3 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR176","doi-asserted-by":"publisher","unstructured":"Seth, P. P. et al. Design, synthesis and evaluation of constrained methoxyethyl (cMOE) and constrained ethyl (cEt) nucleoside analogs. Nucleic Acids Symp. Ser. https:\/\/doi.org\/10.1093\/nass\/nrn280 (2008).","DOI":"10.1093\/nass\/nrn280"},{"key":"1927_CR177","doi-asserted-by":"crossref","unstructured":"Biscans, A. et al. Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles. Mol. Ther. 29, 1382\u20131394 (2020).","DOI":"10.1016\/j.ymthe.2020.12.023"},{"key":"1927_CR178","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1093\/nar\/gkz354","volume":"47","author":"TP Prakash","year":"2019","unstructured":"Prakash, T. P. et al. Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle. Nucleic Acids Res. 47, 6029\u20136044 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR179","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/nat.2019.0794","volume":"29","author":"S Wang","year":"2019","unstructured":"Wang, S., Allen, N., Prakash, T. P., Liang, X.-H. & Crooke, S. T. Lipid conjugates enhance endosomal release of antisense oligonucleotides into cells. Nucleic Acid Ther. 29, 245\u2013255 (2019).","journal-title":"Nucleic Acid"},{"key":"1927_CR180","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","volume":"40","author":"KM Brown","year":"2022","unstructured":"Brown, K. M. et al. Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates. Nat. Biotechnol. 40, 1500\u20131508 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR181","first-page":"e3401","volume":"24","author":"S Ali","year":"2021","unstructured":"Ali, S. et al. Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery. J. Gene Med. 24, e3401 (2021).","journal-title":"J."},{"key":"1927_CR182","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23, 265\u2013280 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"1927_CR183","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/ja505986a","volume":"136","author":"JK Nair","year":"2014","unstructured":"Nair, J. K. et al. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc. 136, 16958\u201316961 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"1927_CR184","doi-asserted-by":"crossref","unstructured":"Brown, C. R. et al. Investigating the pharmacodynamic durability of GalNAc\u2013siRNA conjugates. Nucleic Acids Res. 48, 11827\u201311844 (2020).","DOI":"10.1093\/nar\/gkaa670"},{"key":"1927_CR185","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","volume":"28","author":"AJ Debacker","year":"2020","unstructured":"Debacker, A. J., Voutila, J., Catley, M., Blakey, D. & Habib, N. Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug. Mol. Ther. 28, 1759\u20131771 (2020).","journal-title":"Mol. Ther."},{"key":"1927_CR186","doi-asserted-by":"publisher","first-page":"8298\u20138302","DOI":"10.1073\/pnas.92.18.8298","volume":"92","author":"TM Woolf","year":"1995","unstructured":"Woolf, T. M., Chase, J. M. & Stinchcomb, D. T. Toward the therapeutic editing of mutated RNA sequences. Proc. Natl Acad. Sci. USA 92, 8298\u20138302 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1927_CR187","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/jm801294h","volume":"52","author":"PP Seth","year":"2009","unstructured":"Seth, P. P. et al. Short antisense oligonucleotides with novel 2\u2032\u20134\u2032 conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animals. J. Med. Chem. 52, 10\u201313 (2009).","journal-title":"J. Med. Chem."},{"key":"1927_CR188","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1093\/nar\/gkq505","volume":"38","author":"A Eichert","year":"2010","unstructured":"Eichert, A. et al. The crystal structure of an \u2018all locked\u2019 nucleic acid duplex. Nucleic Acids Res. 38, 6729\u20136736 (2010).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR189","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1021\/ja012288d","volume":"124","author":"M Petersen","year":"2002","unstructured":"Petersen, M., Bondensgaard, K., Wengel, J. & Jacobsen, J. P. Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids. J. Am. Chem. Soc. 124, 5974\u20135982 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"1927_CR190","doi-asserted-by":"crossref","unstructured":"Brinkman, H. F., Jauregui Matos, V., Mendoza, H. G., Doherty, E. E. & Beal, P. A. Nucleoside analogs in ADAR guide strands targeting 5\u2032-U\u0332 sites. RSC Chem. Biol. 4, 74\u201383 (2022).","DOI":"10.1039\/D2CB00165A"},{"key":"1927_CR191","doi-asserted-by":"crossref","unstructured":"Malik, T. N. et al. Regulation of RNA editing by intracellular acidification. Nucleic Acids Res. 49, 4020\u20134036 (2021).","DOI":"10.1093\/nar\/gkab157"},{"key":"1927_CR192","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1172\/JCI0216782","volume":"110","author":"DA Lomas","year":"2002","unstructured":"Lomas, D. A. & Mahadeva, R. \u03b11-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J. Clin. Invest. 110, 1585\u20131590 (2002).","journal-title":"J. Clin. Invest."},{"key":"1927_CR193","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1093\/nar\/gkx587","volume":"45","author":"Y Zheng","year":"2017","unstructured":"Zheng, Y., Lorenzo, C. & Beal, P. A. DNA editing in DNA\/RNA hybrids by adenosine deaminases that act on RNA. Nucleic Acids Res. 45, 3369\u20133377 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1927_CR194","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nbt.3948","volume":"35","author":"N Iwamoto","year":"2017","unstructured":"Iwamoto, N. et al. Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides. Nat. Biotechnol. 35, 845\u2013851 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1927_CR195","doi-asserted-by":"publisher","first-page":"116","DOI":"10.32607\/20758251-2014-6-4-116-118","volume":"6","author":"MS Kupryushkin","year":"2014","unstructured":"Kupryushkin, M. S., Pyshnyi, D. V. & Stetsenko, D. A. Phosphoryl guanidines: a new type of nucleic acid analogues. Acta Naturae 6, 116\u2013118 (2014).","journal-title":"Acta Naturae"},{"key":"1927_CR196","doi-asserted-by":"publisher","first-page":"9784","DOI":"10.3390\/ijms22189784","volume":"22","author":"AS Pavlova","year":"2021","unstructured":"Pavlova, A. S. et al. An influence of modification with phosphoryl guanidine combined with a 2\u2032-O-methyl or 2\u2032-fluoro group on the small-interfering-RNA effect. Int. J. Mol. Sci. 22, 9784 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1927_CR197","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.omtn.2021.11.025","volume":"27","author":"MS Kupryushkin","year":"2022","unstructured":"Kupryushkin, M. S. et al. Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells. Mol. Ther. Nucleic Acids 27, 211\u2013226 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1927_CR198","unstructured":"Cross, R. Watch out, CRISPR. The RNA editing race is on. C&EN (25 March 2019)."},{"key":"1927_CR199","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1021\/cen-09934-buscon16","volume":"99","author":"R Cross","year":"2021","unstructured":"Cross, R. Lilly taps ProQR for RNA editing. CEN Glob. Enterp. 99, 19 (2021).","journal-title":"CEN Glob. Enterp."},{"key":"1927_CR200","unstructured":"Cross, R. RNA-editing race intensifies as big pharma buys in. C&EN (23 October 2021)."},{"key":"1927_CR201","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/d41586-020-00272-5","volume":"578","author":"S Reardon","year":"2020","unstructured":"Reardon, S. A new twist on gene editing. Nature 578, 24\u201327 (2020).","journal-title":"Nature"},{"key":"1927_CR202","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DBT Cox","year":"2015","unstructured":"Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121\u2013131 (2015).","journal-title":"Nat. Med."},{"key":"1927_CR203","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ymthe.2020.03.015","volume":"28","author":"L Teboul","year":"2020","unstructured":"Teboul, L., Herault, Y., Wells, S., Qasim, W. & Pavlovic, G. Variability in genome editing outcomes: challenges for research reproducibility and clinical safety. Mol. Ther. 28, 1422\u20131431 (2020).","journal-title":"Mol. Ther."},{"key":"1927_CR204","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.molmed.2022.01.003","volume":"28","author":"S Zolotukhin","year":"2022","unstructured":"Zolotukhin, S. & Vandenberghe, L. H. AAV capsid design: a Goldilocks challenge. Trends Mol. Med. 28, 183\u2013193 (2022).","journal-title":"Trends Mol. Med."},{"key":"1927_CR205","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","volume":"27","author":"ST Crooke","year":"2018","unstructured":"Crooke, S. T., Witztum, J. L., Bennett, C. F. & Baker, B. F. RNA-targeted therapeutics. Cell Metab. 27, 714\u2013739 (2018).","journal-title":"Cell Metab."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-023-01927-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-023-01927-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-023-01927-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T12:52:25Z","timestamp":1730119945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-023-01927-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":205,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1927"],"URL":"https:\/\/doi.org\/10.1038\/s41587-023-01927-0","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.S.P. is an inventor on patents related to RNA base editing. T.S. is a cofounder and shareholder of and consultant to AIRNA Bio and an inventor on patents related to RNA base editing.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}